TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H100. A total of 20 filers reported holding TRACON PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $296,000 | -89.3% | 67,567 | -83.0% | 0.01% | -89.8% |
| Q1 2016 | $2,776,000 | -38.0% | 397,085 | -18.1% | 0.12% | -35.2% |
| Q4 2015 | $4,481,000 | -5.4% | 485,000 | 0.0% | 0.18% | -0.5% |
| Q3 2015 | $4,738,000 | -13.8% | 485,000 | 0.0% | 0.18% | 0.0% |
| Q2 2015 | $5,495,000 | -19.3% | 485,000 | 0.0% | 0.18% | -17.2% |
| Q1 2015 | $6,809,000 | – | 485,000 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Puissance Capital Management LP | 76,048 | $178,000 | 0.44% |
| NEA Management Company, LLC | 346,718 | $811,000 | 0.04% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |